{"entity":{"type":"insider","cik":"0001808968","url":"/insider/0001808968","json_url":"/insider/0001808968.json","name":"Klein Matthew B.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":39,"n_filings":28,"first":"2021-01-08","last":"2026-08-06","span_basis":"filed_date"},"name_variants":[{"name":"Klein Matthew B.","source":"filing","n_filings":28,"first_seen":"2021-01-08","last_seen":"2026-08-06"}],"transactions":[{"id":5899979,"accession":"0001808968-26-000017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001808968-26-000017","line_url":"/filing/0001808968-26-000017#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10292.0,"shares_display":"10,292","price_per_share":68.57,"price_display":"68.57","price_state":"stated","total_value":705722.44,"total_display":"705,722.44","total_whole":"705,722","shares_owned_after":383868.0,"shares_owned_after_display":"383,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-04","filed_date":"2026-08-06","scope":"insider"},{"id":6177464,"accession":"0001193125-26-239431","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-239431","line_url":"/filing/0001193125-26-239431#line-1","is_derivative":false,"issuer_cik":"0001285550","issuer_name":"ClearPoint Neuro, Inc.","issuer_ticker":"CLPT","issuer_name_source":null,"issuer_url":"/issuer/0001285550","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16000.0,"shares_display":"16,000","price_per_share":11.59,"price_display":"11.59","price_state":"stated","total_value":185440.0,"total_display":"185,440.00","total_whole":"185,440","shares_owned_after":46935.0,"shares_owned_after_display":"46,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-21","filed_date":"2026-05-26","scope":"insider"},{"id":6062225,"accession":"0001808968-26-000015","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001808968-26-000015","line_url":"/filing/0001808968-26-000015","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12572.0,"shares_display":"12,572","price_per_share":72.95207922367165,"price_display":"72.95","price_state":"stated","total_value":917153.54,"total_display":"917,153.54","total_whole":"917,154","shares_owned_after":398670.0,"shares_owned_after_display":"398,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-14","filed_date":"2026-05-15","scope":"insider","n_lines":4},{"id":6116283,"accession":"0001808968-26-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001808968-26-000013","line_url":"/filing/0001808968-26-000013#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2850.0,"shares_display":"2,850","price_per_share":70.91,"price_display":"70.91","price_state":"stated","total_value":202093.5,"total_display":"202,093.50","total_whole":"202,094","shares_owned_after":394070.0,"shares_owned_after_display":"394,070","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-21","filed_date":"2026-04-23","scope":"insider"},{"id":5829366,"accession":"0001808968-26-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001808968-26-000011","line_url":"/filing/0001808968-26-000011#line-2","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2662.0,"shares_display":"2,662","price_per_share":64.08,"price_display":"64.08","price_state":"stated","total_value":170580.96,"total_display":"170,580.96","total_whole":"170,581","shares_owned_after":396920.0,"shares_owned_after_display":"396,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-12","filed_date":"2026-03-13","scope":"insider"},{"id":5789271,"accession":"0001808968-26-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001808968-26-000009","line_url":"/filing/0001808968-26-000009#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7371.0,"shares_display":"7,371","price_per_share":69.36,"price_display":"69.36","price_state":"stated","total_value":511252.56,"total_display":"511,252.56","total_whole":"511,253","shares_owned_after":387082.0,"shares_owned_after_display":"387,082","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-18","filed_date":"2026-02-20","scope":"insider"},{"id":5935796,"accession":"0001808968-26-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001808968-26-000007","line_url":"/filing/0001808968-26-000007#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2514.0,"shares_display":"2,514","price_per_share":76.45,"price_display":"76.45","price_state":"stated","total_value":192195.3,"total_display":"192,195.30","total_whole":"192,195","shares_owned_after":394453.0,"shares_owned_after_display":"394,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-08","filed_date":"2026-01-12","scope":"insider"},{"id":5816490,"accession":"0001808968-26-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001808968-26-000005","line_url":"/filing/0001808968-26-000005#line-2","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3016.0,"shares_display":"3,016","price_per_share":77.48,"price_display":"77.48","price_state":"stated","total_value":233679.68,"total_display":"233,679.68","total_whole":"233,680","shares_owned_after":396967.0,"shares_owned_after_display":"396,967","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-07","filed_date":"2026-01-08","scope":"insider"},{"id":5816488,"accession":"0001808968-26-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001808968-26-000005","line_url":"/filing/0001808968-26-000005#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5149.0,"shares_display":"5,149","price_per_share":76.95,"price_display":"76.95","price_state":"stated","total_value":396215.55,"total_display":"396,215.55","total_whole":"396,216","shares_owned_after":399983.0,"shares_owned_after_display":"399,983","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-06","filed_date":"2026-01-08","scope":"insider"},{"id":5758999,"accession":"0001808968-26-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001808968-26-000001","line_url":"/filing/0001808968-26-000001#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8089.0,"shares_display":"8,089","price_per_share":76.64,"price_display":"76.64","price_state":"stated","total_value":619940.96,"total_display":"619,940.96","total_whole":"619,941","shares_owned_after":341875.0,"shares_owned_after_display":"341,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-30","filed_date":"2026-01-02","scope":"insider"},{"id":4685544,"accession":"0001808968-25-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001808968-25-000003","line_url":"/filing/0001808968-25-000003#line-2","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3428.0,"shares_display":"3,428","price_per_share":79.07,"price_display":"79.07","price_state":"stated","total_value":271051.96,"total_display":"271,051.96","total_whole":"271,052","shares_owned_after":349964.0,"shares_owned_after_display":"349,964","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-02","filed_date":"2025-12-03","scope":"insider"},{"id":4054798,"accession":"0001415889-25-021130","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-021130","line_url":"/filing/0001415889-25-021130#line-2","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10739.0,"shares_display":"10,739","price_per_share":51.74,"price_display":"51.74","price_state":"stated","total_value":555635.86,"total_display":"555,635.86","total_whole":"555,636","shares_owned_after":337767.0,"shares_owned_after_display":"337,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-05","filed_date":"2025-08-05","scope":"insider"},{"id":4146385,"accession":"0001415889-25-011290","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-011290","line_url":"/filing/0001415889-25-011290#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2804.0,"shares_display":"2,804","price_per_share":48.736,"price_display":"48.74","price_state":"stated","total_value":136655.744,"total_display":"136,655.74","total_whole":"136,656","shares_owned_after":273234.0,"shares_owned_after_display":"273,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-22","filed_date":"2025-04-24","scope":"insider"},{"id":4210591,"accession":"0001415889-25-005136","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-005136","line_url":"/filing/0001415889-25-005136#line-2","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3895.0,"shares_display":"3,895","price_per_share":50.124,"price_display":"50.12","price_state":"stated","total_value":195232.98,"total_display":"195,232.98","total_whole":"195,233","shares_owned_after":276038.0,"shares_owned_after_display":"276,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-20","filed_date":"2025-02-21","scope":"insider"},{"id":4210587,"accession":"0001415889-25-005136","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-005136","line_url":"/filing/0001415889-25-005136#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3897.0,"shares_display":"3,897","price_per_share":50.096,"price_display":"50.10","price_state":"stated","total_value":195224.112,"total_display":"195,224.11","total_whole":"195,224","shares_owned_after":279933.0,"shares_owned_after_display":"279,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-21","scope":"insider"},{"id":4804885,"accession":"0001415889-25-001293","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-001293","line_url":"/filing/0001415889-25-001293#line-2","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2402.0,"shares_display":"2,402","price_per_share":44.5,"price_display":"44.50","price_state":"stated","total_value":106889.0,"total_display":"106,889.00","total_whole":"106,889","shares_owned_after":283830.0,"shares_owned_after_display":"283,830","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-08","filed_date":"2025-01-10","scope":"insider"},{"id":4804880,"accession":"0001415889-25-001293","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-001293","line_url":"/filing/0001415889-25-001293#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2142.0,"shares_display":"2,142","price_per_share":45.34,"price_display":"45.34","price_state":"stated","total_value":97118.28,"total_display":"97,118.28","total_whole":"97,118","shares_owned_after":286232.0,"shares_owned_after_display":"286,232","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-07","filed_date":"2025-01-10","scope":"insider"},{"id":5121896,"accession":"0001415889-25-000580","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-000580","line_url":"/filing/0001415889-25-000580#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8279.0,"shares_display":"8,279","price_per_share":45.16,"price_display":"45.16","price_state":"stated","total_value":373879.64,"total_display":"373,879.64","total_whole":"373,880","shares_owned_after":217528.0,"shares_owned_after_display":"217,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-31","filed_date":"2025-01-03","scope":"insider"},{"id":2155724,"accession":"0001415889-24-011329","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-011329","line_url":"/filing/0001415889-24-011329#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3361.0,"shares_display":"3,361","price_per_share":24.894,"price_display":"24.89","price_state":"stated","total_value":83668.734,"total_display":"83,668.73","total_whole":"83,669","shares_owned_after":225807.0,"shares_owned_after_display":"225,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-19","filed_date":"2024-04-22","scope":"insider"},{"id":2222243,"accession":"0001415889-24-011247","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-011247","line_url":"/filing/0001415889-24-011247#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1307.0,"shares_display":"1,307","price_per_share":25.135,"price_display":"25.14","price_state":"stated","total_value":32851.445,"total_display":"32,851.44","total_whole":"32,851","shares_owned_after":229168.0,"shares_owned_after_display":"229,168","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-17","filed_date":"2024-04-19","scope":"insider"},{"id":2927657,"accession":"0001415889-24-000915","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-000915","line_url":"/filing/0001415889-24-000915#line-2","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5443.0,"shares_display":"5,443","price_per_share":29.0148,"price_display":"29.01","price_state":"stated","total_value":157927.5564,"total_display":"157,927.56","total_whole":"157,928","shares_owned_after":160475.0,"shares_owned_after_display":"160,475","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-09","filed_date":"2024-01-10","scope":"insider"},{"id":2927654,"accession":"0001415889-24-000915","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-000915","line_url":"/filing/0001415889-24-000915#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2237.0,"shares_display":"2,237","price_per_share":28.6403,"price_display":"28.64","price_state":"stated","total_value":64068.3511,"total_display":"64,068.35","total_whole":"64,068","shares_owned_after":165918.0,"shares_owned_after_display":"165,918","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-08","filed_date":"2024-01-10","scope":"insider"},{"id":2039275,"accession":"0001415889-24-000854","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-000854","line_url":"/filing/0001415889-24-000854#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10107.0,"shares_display":"10,107","price_per_share":27.1488,"price_display":"27.15","price_state":"stated","total_value":274392.9216,"total_display":"274,392.92","total_whole":"274,393","shares_owned_after":168155.0,"shares_owned_after_display":"168,155","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-05","filed_date":"2024-01-09","scope":"insider"},{"id":8304529,"accession":"0001415889-23-006750","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-006750","line_url":"/filing/0001415889-23-006750#line-2","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF EXECUTIVE OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1211.0,"shares_display":"1,211","price_per_share":52.0437,"price_display":"52.04","price_state":"stated","total_value":63024.9207,"total_display":"63,024.92","total_whole":"63,025","shares_owned_after":102645.0,"shares_owned_after_display":"102,645","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-18","filed_date":"2023-04-20","scope":"insider"},{"id":7874953,"accession":"0001415889-23-000879","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-000879","line_url":"/filing/0001415889-23-000879#line-2","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2244.0,"shares_display":"2,244","price_per_share":44.3596,"price_display":"44.36","price_state":"stated","total_value":99542.9424,"total_display":"99,542.94","total_whole":"99,543","shares_owned_after":77856.0,"shares_owned_after_display":"77,856","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-11","filed_date":"2023-01-12","scope":"insider"},{"id":7874949,"accession":"0001415889-23-000879","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-000879","line_url":"/filing/0001415889-23-000879#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2273.0,"shares_display":"2,273","price_per_share":42.9329,"price_display":"42.93","price_state":"stated","total_value":97586.4817,"total_display":"97,586.48","total_whole":"97,586","shares_owned_after":80100.0,"shares_owned_after_display":"80,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-10","filed_date":"2023-01-12","scope":"insider"},{"id":8383097,"accession":"0001415889-23-000836","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-000836","line_url":"/filing/0001415889-23-000836#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":731.0,"shares_display":"731","price_per_share":41.6562,"price_display":"41.66","price_state":"stated","total_value":30450.6822,"total_display":"30,450.68","total_whole":"30,451","shares_owned_after":82373.0,"shares_owned_after_display":"82,373","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2023-01-11","scope":"insider"},{"id":6617988,"accession":"0001415889-22-004211","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-004211","line_url":"/filing/0001415889-22-004211#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":897.0,"shares_display":"897","price_per_share":42.515,"price_display":"42.52","price_state":"stated","total_value":38135.955,"total_display":"38,135.96","total_whole":"38,136","shares_owned_after":56564.0,"shares_owned_after_display":"56,564","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-19","filed_date":"2022-04-21","scope":"insider"},{"id":6721319,"accession":"0001179110-22-000397","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-22-000397","line_url":"/filing/0001179110-22-000397#line-3","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":775.0,"shares_display":"775","price_per_share":38.525,"price_display":"38.52","price_state":"stated","total_value":29856.875,"total_display":"29,856.88","total_whole":"29,857","shares_owned_after":16461.0,"shares_owned_after_display":"16,461","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-07","filed_date":"2022-01-11","scope":"insider"},{"id":4736341,"accession":"0001179110-21-004535","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-21-004535","line_url":"/filing/0001179110-21-004535","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1641.0,"shares_display":"1,641","price_per_share":46.742505179768436,"price_display":"46.74","price_state":"stated","total_value":76704.451,"total_display":"76,704.45","total_whole":"76,704","shares_owned_after":17006.0,"shares_owned_after_display":"17,006","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-20","filed_date":"2021-04-21","scope":"insider","n_lines":2},{"id":4736335,"accession":"0001179110-21-004535","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-21-004535","line_url":"/filing/0001179110-21-004535#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":859.0,"shares_display":"859","price_per_share":48.168,"price_display":"48.17","price_state":"stated","total_value":41376.312,"total_display":"41,376.31","total_whole":"41,376","shares_owned_after":18450.0,"shares_owned_after_display":"18,450","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-19","filed_date":"2021-04-21","scope":"insider"},{"id":5111769,"accession":"0001179110-21-000733","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-21-000733","line_url":"/filing/0001179110-21-000733#line-2","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4300.0,"shares_display":"4,300","price_per_share":69.088,"price_display":"69.09","price_state":"stated","total_value":297078.4,"total_display":"297,078.40","total_whole":"297,078","shares_owned_after":19309.0,"shares_owned_after_display":"19,309","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-20","scope":"insider"},{"id":4595129,"accession":"0001179110-21-000539","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-21-000539","line_url":"/filing/0001179110-21-000539","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":69.71090909090908,"price_display":"69.71","price_state":"stated","total_value":383410.0,"total_display":"383,410.00","total_whole":"383,410","shares_owned_after":20809.0,"shares_owned_after_display":"20,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-08","filed_date":"2021-01-12","scope":"insider","n_lines":2},{"id":5111735,"accession":"0001179110-21-000467","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-21-000467","line_url":"/filing/0001179110-21-000467#line-3","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001808968","owner_name":"Klein Matthew B.","owner_display_name":"Klein Matthew B.","owner_url":"/insider/0001808968","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3886.0,"shares_display":"3,886","price_per_share":68.98,"price_display":"68.98","price_state":"stated","total_value":268056.28,"total_display":"268,056.28","total_whole":"268,056","shares_owned_after":19309.0,"shares_owned_after_display":"19,309","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-07","filed_date":"2021-01-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":39,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":39,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":39},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001070081","name":"PTC THERAPEUTICS, INC.","url":"/issuer/0001070081","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","n_filings":27,"first_seen":"2021-01-08","last_seen":"2026-08-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001285550","name":"ClearPoint Neuro, Inc.","url":"/issuer/0001285550","role":"Director","n_filings":1,"first_seen":"2026-05-26","last_seen":"2026-05-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001808968","retrieved_at":"2026-08-26T09:05:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}